Trump had over 80 clinical trials of medications ongoing from Feb 2020, trying to find something that worked.
This upcoming tox study of an experimental external application of antibody is promising news. Unfortunately, it’s time to market will be about 3 years after the start of the pandemic (clinical 2022 trials mean a 2023 release/widely=avail). I sure hope CCPvirus has been ghosted before then and we won’t need an antibody inhaler.
OTOH, powdered treatments for the lungs could lead to improved and targeted treatments for lung cancer, copd and emphysema. So keep the experiments going!
That is frequency. Find the proper frequency that destroys a harmful cell and you have a treatment. Tesla was a genius.
...powdered treatments for the lungs...
______________________________________
Not sure, but isn’t budesinide administered in hospital as an inhaled powder? Thought I came across that somewhere.